EMEA-002600-PIP03-21

Table of contents

Key facts

Invented name
Aspaveli
Active substance
Pegcetacoplan
Therapeutic area
Uro-nephrology
Decision number
P/0284/2022
PIP number
EMEA-002600-PIP03-21
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of glomerulonephritis and nephrotic syndrome
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Apellis Ireland Limited

E-mail: info@apellis.com
Tel: +1 6179775700

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

Related content

How useful was this page?

Add your rating